These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 33579161

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P, Choolam A, Kulkantrakorn K.
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Histologic features of human orbicularis oculi treated with botulinum A toxin.
    Harris CP, Alderson K, Nebeker J, Holds JB, Anderson RL.
    Arch Ophthalmol; 1991 Mar; 109(3):393-5. PubMed ID: 2003801
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [The role of botulinum toxin in the treatment of essential blepharospasm].
    Safran AB.
    Schweiz Rundsch Med Prax; 1990 Nov 27; 79(48):1512-4. PubMed ID: 2255835
    [Abstract] [Full Text] [Related]

  • 52. Pretarsal blepharospasm: Clinical and electromyographic characteristics.
    Grandas F, Traba A, Perez-Sanchez JR, Esteban A.
    Clin Neurophysiol; 2020 Jul 27; 131(7):1678-1685. PubMed ID: 32280019
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Management of blepharospasm.
    Kennedy RH, Waller RR, Henderson JW, Kesty KR.
    Ophthalmic Plast Reconstr Surg; 1985 Jul 27; 1(4):253-61. PubMed ID: 3940140
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog.
    Meyer-Lindenberg A, Wohlfarth KM, Switzer EN.
    Aust Vet J; 2003 Oct 27; 81(10):612-4. PubMed ID: 15080472
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Frontalis suspension in the treatment of essential blepharospasm unresponsive to botulinum-toxin therapy: long-term results.
    Roggenkämper P, Nüssgens Z.
    Graefes Arch Clin Exp Ophthalmol; 1997 Aug 27; 235(8):486-9. PubMed ID: 9285216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.